New cord blood treatment tested for tough leukemia
NCT ID NCT07256353
Summary
This early-stage study is testing a new type of cell therapy for adults with a hard-to-treat blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). The therapy uses immune cells (CAR-T cells) made from donated umbilical cord blood, not the patient's own cells. Researchers will give the treatment to up to 50 adults to check its safety, find the best dose, and see if it can put the cancer into remission.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The General Hospital of Western Theater Command
Chengdu, Sichuan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.